Sonoma Orthopedic Products has raised $22m for its series D round from a consortium led by Ascension Health’s corporate venturing unit as a new investor and used part of the money to buy assets from NovaLign Orthopaedics.
Alongside Ascension Health Ventures in the D round consortium are venture capital firms Split Rock Partners, Legacy Life Sciences, EDF Ventures, MedVenture Associates, DFJ InCube Ventures, Emergent Medical Partners and Asset Management Partners.
Walter Lin of Ascension Health Ventures, which acts as the manager for the CHV II limited partnership between Ascension Health, Catholic Health Initiatives, Catholic Health East, and Catholic Healthcare West, has joined Sonoma’s board and said: "Sonoma’s unique flexible-to-rigid WaviBody and TaperBody platform technologies address a clear clinical need in orthopedic trauma care [by the minimally invasive repair of fractured bone]."
Founded in 2006 Sonoma raised $12m in April 2009’s C round and $13m previously.